相关实验视频

Updated: Sep 15, 2025

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

验证加拿大囊性纤维化注册表数据的完整性和准确性

Ranjani Somayaji¹, Stephanie Y Cheng², Noma Abdulrahem²

¹Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada.

Canadian respiratory journal

|July 15, 2025

概括

加拿大囊性纤维化注册 (CCFR) 数据对于临床研究来说非常准确. 验证证实,CCFR中的人口和临床数据对于研究囊性纤维化 (CF) 护理是可靠的.

科学领域:

医疗信息学医疗信息学
流行病学流行病学
临床研究临床研究

背景情况:

加拿大囊性纤维化注册 (CCFR) 自20世纪70年代以来一直在收集纵向数据.
CCFR包含加拿大各地患有囊性纤维化 (CF) 的人口统计和临床信息.
了解注册数据的准确性对于可靠的临床研究和流行病学研究至关重要.

研究的目的:

验证加拿大囊性纤维化注册 (CCFR) 数据的准确性.
确定CCFR数据收集过程中的潜在局限性.
确保CCFR数据的可靠性,用于临床研究和患者护理.

主要方法:

八个认可的加拿大囊性纤维化 (CF) 诊所被随机选择.
来自2019年每个选定的诊所的15%患者的随机样本被选择用于验证.
记录数据的准确性与医疗记录进行了比较,数据被分类为正确,不正确或无法验证.

主要成果:

验证队列包括来自8个代表性CF诊所的208名患者.
关于临床测量,治疗和住院治疗的CCFR数据中约95%是准确的.
人口统计数据,包括性别和出生日期,显示出100%的准确性.

结论:

验证研究证实了加拿大囊性纤维化注册表 (CCFR) 的高准确性.
对临床和人口统计变量的CCFR数据可靠,可用于临床研究.
这些发现支持继续使用CCFR来推进囊性纤维化研究和护理.

更多相关视频

Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis

Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis

Published on: June 10, 2022

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

相关概念视频

Cystic Fibrosis: Pathogenesis

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...